Science at speed: Unlocking Rapid Development for Biologics and Advanced Therapies
From drug discovery through CMC, to GMP, end-to-end services accelerating plasmid, antibody, and cell & gene therapy development and manufacturing.
Next generation biologics and cell & gene therapies combine biological complexity with demanding manufacturing and evolving regulatory expectations. Accessing scientific expertise early can accelerate your path to commercialization.
Developers need more than capacity; they need a CDMO with innovation depth, cross platform capabilities, regulatory support and early CMC and IND commercial guidance to accelerate programs with confidence.
ProBio, brings multimodality support from discovery to GMP. In June 2025, we opened our flagship Cell & Gene Therapy Center of Excellence in Hopewell, New Jersey, strengthening our global CGT ecosystem. We also offer an end‑to‑end in vivo CAR-T solution with both LVV and tLNP technologies and support for IIT-driven innovation.
*Probio is a subsidiary of GenScript.
Comprehensive Platforms from Biologics to CGT
From biologics to CGT, ProBio has a global footprint covering plasmid, viral vectors, mRNA and biologics. With over 150 GMP batches completed in biologics and over 700 clinical batches manufactured in CGT, we bring proven expertise to accelerate advanced therapy programs.
DownloadIn vivo CAR-T One-stop Solution
ProBio’s differentiated, end‑to‑end solution for in‑vivo CAR‑T development, provides a one stop solution with flexibility. This dual‑modality approach enables you to choose the optimal delivery strategy without fragmenting your development across multiple partners.
DownloadGene Therapy Clinical Manufacturing from Plasmid to AAV
ProBio, using its proprietary suspension cell line, with triple transient transfection system, provides a robust and high-quality AAV vector manufacturing platform.
DownloadmRNA Vaccine Manufacturing
From plasmid to linearized DNA to IVT-mRNA to mRNA-LNP, ProBio provides a 6-Month One-stop Solution for IND Filing.
DownloadAntibody Discovery Services
ProBio Biologics Discovery Center leverages 20 years of experience in biologics discovery to offer end-to-end services from target to preclinical candidates (PCC). We are dedicated to accelerating your biologics discovery process of getting potential PCCs with functionality and developability.
DownloadProtein and Antibody Drug Services
ProBio enables the efficient development of complex molecules. Our cutting‑edge biologics discovery and developability platforms deliver high‑quality candidates, optimized for success. With deep expertise in proteins and bispecifics, we streamline the path from discovery to IND and GMP, helping you advance programs with speed and confidence.
DownloadOvercoming Technology Transfer Hurdles
Technology transfer is a challenge for any company, as moving between facilities leads to differences in equipment, facilities, quality systems, and personnel. This handbook is a brief introduction to the process and key elements in technology transfer.
Download